Neogen Corp Files 8-K: Director & Officer Changes
Ticker: NEOG · Form: 8-K · Filed: Oct 30, 2025 · CIK: 711377
| Field | Detail |
|---|---|
| Company | Neogen Corp (NEOG) |
| Form Type | 8-K |
| Filed Date | Oct 30, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.16, $2 billion, $600,000, $2,000,000, $2,250,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, officer-changes, financial-reporting
Related Tickers: NEOG
TL;DR
NEOG 8-K: Board & exec changes filed 10/30. Watch for governance updates.
AI Summary
On October 30, 2025, Neogen Corporation filed an 8-K report detailing changes in its board of directors and executive officers, along with updates on compensatory arrangements. The filing also includes financial statements and exhibits, indicating ongoing corporate governance and financial reporting activities for the company.
Why It Matters
This filing signals potential shifts in leadership and compensation structures at Neogen Corporation, which could impact strategic direction and investor confidence.
Risk Assessment
Risk Level: low — The filing primarily concerns routine corporate governance and financial reporting, with no immediate indication of significant financial distress or operational disruption.
Key Players & Entities
- Neogen Corporation (company) — Registrant
- October 30, 2025 (date) — Date of earliest event reported
FAQ
What specific changes were made to Neogen Corporation's board of directors or executive officers?
The filing indicates changes related to the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers' and 'Compensatory Arrangements of Certain Officers', but the specific details of these changes are not provided in the excerpt.
What is the significance of the 'Other Events' item in this 8-K filing?
The 'Other Events' item suggests that Neogen Corporation is reporting events not covered by other standard 8-K items, the specifics of which are not detailed in the provided text.
What type of financial statements are included with this filing?
The filing lists 'Financial Statements and Exhibits' as an item, but the specific nature or content of these financial statements is not elaborated upon in the excerpt.
When was Neogen Corporation incorporated and in which state?
Neogen Corporation was incorporated in Michigan, as indicated by the 'State of Incorporation' field.
What is Neogen Corporation's Standard Industrial Classification (SIC) code and description?
Neogen Corporation's SIC code is 2835, which corresponds to 'IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES'.
Filing Stats: 1,042 words · 4 min read · ~3 pages · Grade level 12.2 · Accepted 2025-10-30 08:47:15
Key Financial Figures
- $0.16 — nge on which registered Common Stock, $0.16 par value per share NEOG Nasdaq Glo
- $2 billion — al Officer, North America, overseeing a $2 billion business and multiple manufacturing sit
- $600,000 — Base Salary : An annual base salary of $600,000. Annual Bonus : Eligible to participa
- $2,000,000 — annual grant of equity with a target of $2,000,000 in value at grant with a composition as
- $2,250,000 — al, one-time equity inducement grant of $2,250,000, comprised of 50% stock options with a
- $250,000 — e will receive a one-time cash award of $250,000 to be paid by December 31, 2025, which
Filing Documents
- neog-20251030.htm (8-K) — 55KB
- neog-ex10_1.htm (EX-10.1) — 22KB
- neog-ex99_1.htm (EX-99.1) — 11KB
- 0001193125-25-257565.txt ( ) — 200KB
- neog-20251030.xsd (EX-101.SCH) — 24KB
- neog-20251030_htm.xml (XML) — 5KB
01 Other Events
Item 8.01 Other Events. On October 30, 2025, Neogen issued a press release announcing the appointment of a new Chief Financial Officer.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits 10.1 Offer Letter between Neogen Corporation and Bryan Riggsbee dated October 24, 2025. 99.1 Press Release issued by Neogen Corporation on October 30, 2025, announcing appointment of Bryan Riggsbee as Senior Vice President and Chief Financial Officer. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NEOGEN CORPORATION Date: October 30, 2025 By: /s/ Amy M. Rocklin Name: Amy M. Rocklin Title: Chief Legal & Compliance Officer, Corporate Secretary